Your browser doesn't support javascript.
loading
Corrigendum to "Reversal of the deleterious effects of chronic dietary HFCS-55 intake by PPAR-δ agonism correlates with impaired NLRP3 inflammasome activation'' [Biochem. Pharmacol. 85(2) (2013) 257-264].
Collino, Massimo; Benetti, Elisa; Rogazzo, Mara; Mastrocola, Raffaella; Yaqoob, Muhammed M; Aragno, Manuela; Theimermann, Christroph; Fantozzi, Roberto.
Afiliação
  • Collino M; Department of Drug and Technology, University of Turin, Turin, Italy. Electronic address: massimo.collino@unito.it.
  • Benetti E; Department of Drug and Technology, University of Turin, Turin, Italy.
  • Rogazzo M; Department of Drug and Technology, University of Turin, Turin, Italy.
  • Mastrocola R; Department of Experimental Medicine and Oncology, University of Turin, Turin, Italy.
  • Yaqoob MM; Centre of Traslational Medicine and Therapeutics, William Harvey Research Institute, Barts and the London School of Medicine and Dentisry, Queen Mary University of London, London, UK.
  • Aragno M; Department of Experimental Medicine and Oncology, University of Turin, Turin, Italy.
  • Theimermann C; Centre of Traslational Medicine and Therapeutics, William Harvey Research Institute, Barts and the London School of Medicine and Dentisry, Queen Mary University of London, London, UK.
  • Fantozzi R; Department of Drug and Technology, University of Turin, Turin, Italy.
Biochem Pharmacol ; 222: 116060, 2024 Apr.
Article em En | MEDLINE | ID: mdl-38430671
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Biochem Pharmacol Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Biochem Pharmacol Ano de publicação: 2024 Tipo de documento: Article